Initiate a suite of clinical trials in 2025 intended to support global registration of NX-5948 for the treatment of chronic lymphocytic ...

5x30 Path to growth and value creation The company intends to achieve the following five objectives by 2030 (“5x30 ... timing and success of U.S. Food and Drug Administration supplemental New Drug ...

PARSIPPANY, N.J., Jan. 10, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the ...

The OFR/GPO partnership is committed to presenting accurate and reliable regulatory information on FederalRegister.gov with the objective of establishing the XML-based Federal Register as an ...

An FDA optometry roundup discusses changes in drug approvals and devices used by optometric eye care professionals.

Shujun Wang seemed to be a Chinese democracy activist, but an F.B.I. investigation showed just how far China will go to ...

Tuesday marks President Donald Trump's first full day in office. Keep up with the USA TODAY Network's coverage of his top ...

The Australian Public Service in the 1970s saw a period of economic restraint – and major technology and social change.

When Japanese engineer Eiji Nakatsu was designing the new 500-series Shinkansen bullet train in the 1990s, he was looking for ...

The talk-show host Yinon Magal is at the center of a campaign to protect the Prime Minister and destroy the opposition.

ZILRETTA and iovera°; the related timing and success of U.S. Food and Drug Administration supplemental New Drug Applications and premarket notification 510(k)s; the related timing and success of ...

Google Deepmind co-founder Demis Hassabis talks to FT editor Roula Khalaf about the real world healthcare applications of AI and how his ground-breaking work on the structure of proteins could acceler ...